NPR: The government may soon lift restrictions on some peptide treatments Peer-reviewed
FDA Peptide Reclassification 2026: What It Means for Longevity Clinics and Patients
HHS Secretary Kennedy announced ~14 peptides will move from Category 2 (restricted) to Category 1 (legal for compounding). Here's what the reclassification means for longevity medicine, which peptides are returning, and why physician oversight matters more than ever.